Summary
JPMorgan upgraded specialty chemicals maker Celanese to an Overweight rating from Neutral, saying the recent fall in the stock provides a more attractive valuation entry point. The bank set a December 2026 price target of $68 per share and highlighted structural strength in acetyl product markets that it expects to support profit growth and higher cash generation in 2026.
Market move and valuation
In a research note published Tuesday, JPMorgan analyst Jeffrey J. Zekauskas raised Celaneses rating and assigned a $68 target for December 2026. That target stands above Celaneses closing price of $57.17 on May 11. The stock has slid roughly 14% from near $69 last week, even as broader markets advanced, prompting the bank to view the pullback as a valuation opportunity.
Drivers of the recent selloff
JPMorgan said the recent decline reflected investor disappointment with free cash flow expectations and a moderation in geopolitical tensions tied to Iran, a factor that had previously helped keep some commodity prices elevated. Those developments, the bank wrote, contributed to the recent reassessment of the companys near-term outlook by investors.
Acetyl markets and profit outlook
The bank emphasized Celaneses exposure to the global acetyl chain, pointing to sustained tightness in markets for acetic acid, vinyl acetate monomer (VAM), and vinyl acetate ethylene (VAE) as a primary source of upside for earnings. JPMorgan projects 2026 earnings per share of $6.35, up from an estimated $4.02 in 2025.
JPMorgans note singled out persistent supply-chain disruptions and higher chemical prices as key contributors to that earnings improvement. The research cited sharp swings in spot commodity prices in China: acetic acid rose from about $385 per ton in late February to nearly $700 in early April before easing to roughly $450, while VAM climbed from $865 per ton to as high as $1,800 prior to moderating.
Feedstock advantages and segment expectations
The bank also highlighted Celaneses manufacturing footprint, noting that a large North American production base provides a cost advantage for sourcing methanol and ethylene, which are important feedstocks for acetyl products. JPMorgan expects the companys Acetyl Chain division to generate meaningful profit growth in 2026 on the back of these dynamics.
Free cash flow outlook
Celanese recently lifted its 2026 free cash flow guidance to a range of $700 million to $800 million, up from a prior $650 million to $750 million projection. Based on those figures, JPMorgan estimates the company could deliver free cash flow yields of roughly 11% to 13% in both 2026 and 2027.
Takeaway
JPMorgans upgrade rests on a combination of a cheaper share price after a recent pullback and expected strength in acetyl-related end markets, which the bank believes will lift both earnings and cash returns in 2026. The analysts case relies on continued market tightness, elevated chemical pricing relative to recent troughs, and Celaneses cost positioning in North America.